Download TESI DOCTORAL

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

page
1
page
2
page
3
page
4
Document related concepts
no text concepts found
Transcript 
TESI DOCTORAL
CARACTERITZACIÓ DE LA RESPOSTA DE CÈL·LULES
TUMORALS A LES MITRAMICINES
Marc Bataller Chardi
Barcelona, maig de 2009
ANNEX.
Bataller,M., Portugal, J.
Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate
carcinoma cells.
Arch. Biochem. Biophys. 437, 151-158 (2005)
Mansilla, S., Bataller, M., Portugal, J.
Mitotic catastrophe as a consequence of chemotherapy.
Anticancer Agents Med. Chem. 6, 589-602 (2006)
Mansilla, S., Rojas, M., Bataller, M., Priebe, W., Portugal, J.
Circumvention of the multidrug-resistance protein (MRP-1) by an antitumour drug
through specific inhibition of gene transcription in breast tumor cells.
Biochem. Pharmacol. 7, 934-942 (2007)
Bataller, M., Méndez, C., Salas, J.A., Portugal, J.
Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells.
Mol. Cancer Ther. 9, 2988-2897 (2008)
Mansilla, S., Bataller, M., Portugal, J.
A nuclear budding mechanism in transiently arrested cells generates drug-sensitive and
drug-resistant cells.
Biochem. Pharmacol. 78, 123-132 (2009)
Portugal, J., Mansilla, S., Bataller, M.
Mechanisms of drug-induced mitotic catastrophe in cancer cells
Curr. Pharm. Des. –en premsa- (2009)
Bataller, M., Méndez, C., Salas, J.A., Portugal, J.
Apoptosis in p21WAF1-deficient human colon carcinoma cells is stimulated by
mithramycin SK.
Biochem. Pharmacol. –en revisió- (2009)
Related documents